The development and application of regulatory science - which FDA has defined as the science of developing new tools, standards, and approaches to assess the safety, efficacy, quality, and performance of FDA-regulated products - calls for a well-trained, scientifically engaged, and motivated workforce. FDA faces challenges in retaining regulatory scientists and providing them with opportunities for professional development. In the private sector, advancement of innovative regulatory science in drug development has not always been clearly defined, well coordinated, or connected to the needs of the agency. As a follow-up to a 2010 workshop, the IOM held a workshop on September 20-21, 2011, to provide a format for establishing a specific agenda to implement the vision and principles relating to a regulatory science workforce and disciplinary infrastructure as discussed in the 2010 workshop.
"synopsis" may belong to another edition of this title.
Seller: PBShop.store UK, Fairford, GLOS, United Kingdom
PAP. Condition: New. New Book. Shipped from UK. Established seller since 2000. Seller Inventory # GB-9780309222143
Quantity: 1 available
Seller: Rarewaves.com USA, London, LONDO, United Kingdom
Paperback. Condition: New. The development and application of regulatory science - which FDA has defined as the science of developing new tools, standards, and approaches to assess the safety, efficacy, quality, and performance of FDA-regulated products - calls for a well-trained, scientifically engaged, and motivated workforce. FDA faces challenges in retaining regulatory scientists and providing them with opportunities for professional development. In the private sector, advancement of innovative regulatory science in drug development has not always been clearly defined, well coordinated, or connected to the needs of the agency. As a follow-up to a 2010 workshop, the IOM held a workshop on September 20-21, 2011, to provide a format for establishing a specific agenda to implement the vision and principles relating to a regulatory science workforce and disciplinary infrastructure as discussed in the 2010 workshop. Seller Inventory # LU-9780309222143
Quantity: 1 available
Seller: Revaluation Books, Exeter, United Kingdom
Paperback. Condition: Brand New. 120 pages. 9.00x6.00x0.50 inches. In Stock. Seller Inventory # __0309222141
Quantity: 1 available
Seller: Ria Christie Collections, Uxbridge, United Kingdom
Condition: New. In. Seller Inventory # ria9780309222143_new
Quantity: 1 available
Seller: THE SAINT BOOKSTORE, Southport, United Kingdom
Paperback / softback. Condition: New. New copy - Usually dispatched within 3 working days. Seller Inventory # B9780309222143
Quantity: 1 available
Seller: Kennys Bookstore, Olney, MD, U.S.A.
Condition: New. Editor(s): Claiborne, Anne B.; Olson, Steve. Num Pages: 118 pages, Illustrations. Category: (P) Professional & Vocational. Dimension: 229 x 152 x 0. . . 2012. Paperback. . . . . Books ship from the US and Ireland. Seller Inventory # V9780309222143
Seller: Kennys Bookshop and Art Galleries Ltd., Galway, GY, Ireland
Condition: New. Editor(s): Claiborne, Anne B.; Olson, Steve. Num Pages: 118 pages, Illustrations. Category: (P) Professional & Vocational. Dimension: 229 x 152 x 0. . . 2012. Paperback. . . . . Seller Inventory # V9780309222143
Seller: Speedyhen, Hertfordshire, United Kingdom
Condition: NEW. Seller Inventory # NW9780309222143
Quantity: 1 available
Seller: moluna, Greven, Germany
Condition: New. KlappentextrnrnThe development and application of regulatory science - which FDA has defined as the science of developing new tools, standards, and approaches to assess the safety, efficacy, quality, and performance of FDA-regulated products - c. Seller Inventory # 1045495030
Seller: AHA-BUCH GmbH, Einbeck, Germany
Taschenbuch. Condition: Neu. Neuware - The development and application of regulatory science - which FDA has defined as the science of developing new tools, standards, and approaches to assess the safety, efficacy, quality, and performance of FDA-regulated products - calls for a well-trained, scientifically engaged, and motivated workforce. FDA faces challenges in retaining regulatory scientists and providing them with opportunities for professional development. In the private sector, advancement of innovative regulatory science in drug development has not always been clearly defined, well coordinated, or connected to the needs of the agency. As a follow-up to a 2010 workshop, the IOM held a workshop on September 20-21, 2011, to provide a format for establishing a specific agenda to implement the vision and principles relating to a regulatory science workforce and disciplinary infrastructure as discussed in the 2010 workshop. Seller Inventory # 9780309222143